A Phase I Study of MK-0752, a Notch Inhibitor, in Patients with Metastatic or Locally Advanced Breast Cancer and Other Solid Tumors (Merck Protocol No. 014-07).

Trial Profile

A Phase I Study of MK-0752, a Notch Inhibitor, in Patients with Metastatic or Locally Advanced Breast Cancer and Other Solid Tumors (Merck Protocol No. 014-07).

Not stated
Phase of Trial: Phase I

Latest Information Update: 09 Apr 2010

At a glance

  • Drugs MK 0752 (Primary)
  • Indications Advanced breast cancer; Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Apr 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top